CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 121 enrolled
Drug / intervention
Oral Dissolvable Tablet Zofran (ondansetron) +1 moredrug
Likely dose
Oral Dissolvable Tablet Zofran (ondansetron) 4 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03125811
NCT03125811Early Ph 1Completed
CompareCT.gov

Value of Ondansetron Medication vs Inhaled Isopropyl Therapy in the Emergency Department (VOMIITED)

Texas Tech University Health Sciences Center, El Paso·interventional·Posted Apr 24, 2017·Updated Aug 29, 2023

In Brief

A Early Phase 1 clinical trial evaluating Inhaled Isopropyl Alcohol (IPA) and Oral Dissolvable Tablet Zofran (ondansetron) for Nausea and Vomiting. Completed, enrolled 121 participants across 2 sites.

Detailed Summary

This study will compare two different ways to relieve nausea and vomiting in the Emergency Department. The usual treatment for nausea/vomiting is a drug called Zofran, but new studies have suggested that smelling alcohol pads can also help to relieve nausea and vomiting.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNausea, Vomiting
CountriesUnited States
Collaborators--

Timeline

Early Ph 1CompletedFinished
201820192020202120222023202420252026
First PostedApr 24, 2017
Enrollment StartJul 17, 2017
Primary CompletionMar 1, 2023
TodayJul 2, 2026
Enrollment to primary: 5.6 yearsPosted 9.2 years ago

Interventions

Inhaled Isopropyl Alcohol (IPA)other

Three doses within 60 minutes. Doses will occur at 0 minutes, 30 minutes, and 60 minutes. Each dose consists of 3 inhalations of one IPA prep pad. A new prep pad is used at each dose.

Oral Dissolvable Tablet Zofran (ondansetron)drug

Single dose 4 mg tablet at 0 minutes.